Hepatitis Monthly

Published by: Neoscriber Demo Publisher

Influential Factors of Hepatitis B Virus cccDNA in Peripheral Blood Mononuclear Cells Among HBsAg-Positive Pregnant Females Neonates

Xiao-Hong Shi 1 , Bo Wang 2 , Shu-Ying Feng 2 , Zhen Guo 1 , 3 , Jian Guo 1 , 4 , Xue-Fei Wang 1 , Shu-Zhen Li 1 , Yong-Liang Feng 1 and Su-Ping Wang 1 , *
Authors Information
1 Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi Province, China
2 Department of Obstetrics and Gynaecology, The Third People Hospital of Taiyuan City, Taiyuan, Shanxi Province, China
3 Central laboratory, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Province, China
4 School of Public Health, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
Article information
  • Hepatitis Monthly: October 2018, 18 (10); e55064
  • Published Online: April 30, 2018
  • Article Type: Research Article
  • Received: June 16, 2017
  • Revised: December 12, 2017
  • Accepted: April 24, 2018
  • DOI: 10.5812/hepatmon.55064

To Cite: Shi X, Wang B, Feng S, Guo Z, Guo J, et al. Influential Factors of Hepatitis B Virus cccDNA in Peripheral Blood Mononuclear Cells Among HBsAg-Positive Pregnant Females Neonates, Hepat Mon. 2018 ; 18(10):e55064. doi: 10.5812/hepatmon.55064.

Abstract
Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212-9. doi: 10.1016/j.vaccine.2011.12.116. [PubMed: 22273662].
  • 2. Chen Y, Wang L, Xu Y, Liu X, Li S, Qian Q, et al. Role of maternal viremia and placental infection in hepatitis B virus intrauterine transmission. Microbes Infect. 2013;15(5):409-15. doi: 10.1016/j.micinf.2013.02.008. [PubMed: 23500187].
  • 3. Yu M, Jiang Q, Gu X, Ju L, Ji Y, Wu K, et al. Correlation between vertical transmission of hepatitis B virus and the expression of HBsAg in ovarian follicles and placenta. PLoS One. 2013;8(1). e54246. doi: 10.1371/journal.pone.0054246. [PubMed: 23382883].
  • 4. Bai GQ, Li SH, Yue YF, Shi L. The study on role of peripheral blood mononuclear cell in HBV intrauterine infection. Arch Gynecol Obstet. 2011;283(2):317-21. doi: 10.1007/s00404-010-1366-8. [PubMed: 20107823].
  • 5. Gatta A, Giannini C, Lampertico P, Pontisso P, Quarta S, Zignego AL, et al. Hepatotropic viruses: new insights in pathogenesis and treatment. Clin Exp Rheumatol. 2008;26(1 Suppl 48):S33-8. [PubMed: 18570752].
  • 6. Xu YY, Liu HH, Zhong YW, Liu C, Wang Y, Jia LL, et al. Peripheral blood mononuclear cell traffic plays a crucial role in mother-to-infant transmission of hepatitis B virus. Int J Biol Sci. 2015;11(3):266-73. doi: 10.7150/ijbs.10813. [PubMed: 25678845].
  • 7. Xue SL, Wei JN, Wang B, Shuang JY, Feng LP. Association of placental apoptosis and PBMC transfer with HBsAg of PBMC in neonates. Chin J Public Health. 2015;31:199-201. Chinese.
  • 8. Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol. 2004;10(21):3215-7. doi: 10.3748/wjg.v10.i21.3215. [PubMed: 15457579].
  • 9. Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19(2):e18-25. doi: 10.1111/j.1365-2893.2011.01492.x. [PubMed: 22239517].
  • 10. Addison WR, Walters KA, Wong WW, Wilson JS, Madej D, Jewell LD, et al. Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication. J Virol. 2002;76(12):6356-63. doi: 10.1128/JVI.76.12.6356-6363.2002. [PubMed: 12021368].
  • 11. Singh M, Dicaire A, Wakil AE, Luscombe C, Sacks SL. Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR. J Virol Methods. 2004;118(2):159-67. doi: 10.1016/j.jviromet.2004.02.006. [PubMed: 15081611].
  • 12. Torii N, Hasegawa K, Joh R, Hayashi N. Configuration and replication competence of hepatitis B virus DNA in peripheral blood mononuclear cells from chronic hepatitis B patients and patients who have recovered from acute self-limited hepatitis. Hepatol Res. 2003;25(3):234-43. doi: 10.1016/S1386-6346(02)00275-9. [PubMed: 12697244].
  • 13. Cabrerizo M, Bartolome J, Caramelo C, Barril G, Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology. 2000;32(1):116-23. doi: 10.1053/jhep.2000.8541. [PubMed: 10869298].
  • 14. Shi XH, Wang SP, Li SZ, Xie LJ, Feng LP, Shuang JY. Study on replication status of HBsAg positive pregnant women and newborns. Chin J Public Health. 2004;20(5):513-4. Chinese.
  • 15. Fan JS, Zhuang H, Zhu XJ. Comparative study on the clinical and epidemiological characteristics of HBsAg negative and positive hepatitis B in 6 cities in China. Chin J Prev Med. 1996;30(Suppl):17-9. Chinese.
  • 16. Kock J, Theilmann L, Galle P, Schlicht HJ. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology. 1996;23(3):405-13. doi: 10.1002/hep.510230303. [PubMed: 8617418].
  • 17. Guo Z, Shi XH, Feng YL, Wang B, Feng LP, Wang SP, et al. Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women. J Viral Hepat. 2013;20(5):317-21. doi: 10.1111/jvh.12032. [PubMed: 23565613].
  • 18. Shao ZJ, Zhang L, Xu JQ, Xu DZ, Men K, Zhang JX, et al. Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J Med Virol. 2011;83(5):791-5. doi: 10.1002/jmv.22043. [PubMed: 21360547].
  • 19. Chen Y, Sze J, He ML. HBV cccDNA in patients' sera as an indicator for HBV reactivation and an early signal of liver damage. World J Gastroenterol. 2004;10(1):82-5. Chinese. doi: 10.3748/wjg.v10.i1.82. [PubMed: 14695774].
  • 20. Chen L, Wu C, Fan X, Gao J, Yin H, Wang T, et al. Replication and infectivity of hepatitis B virus in HBV-related glomerulonephritis. Int J Infect Dis. 2009;13(3):394-8. doi: 10.1016/j.ijid.2008.08.014. [PubMed: 19036623].
  • 21. Yu MM, Gu XJ, Xia Y, Wang GJ, Kan NY, Wu KH. [Relationship between the expression of HBV DNA, HBV cccDNA in human ovary tissues and the HBV intrauterine infection]. Zhonghua Liu Xing Bing Xue Za Zhi. 2013;34(2):178-82. [PubMed: 23751477].
  • 22. Coffin CS, Mulrooney-Cousins PM, van Marle G, Roberts JP, Michalak TI, Terrault NA. Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy. Liver Transpl. 2011;17(8):955-62. doi: 10.1002/lt.22312. [PubMed: 21462295].
  • 23. Vakili Ghartavol Z, Alavian SM, Amini S, Vahabpour R, Bahramali G, Mostafavi E, et al. Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iran. Hepat Mon. 2013;13(5). e10134. doi: 10.5812/hepatmon.10134. [PubMed: 23967017].
  • 24. Caruntu FA, Molagic V. CccDNA persistence during natural evolution of chronic VHB infection. Rom J Gastroenterol. 2005;14(4):373-7. [PubMed: 16400354].
  • 25. Badur S, Lazizi Y, Ugurlu M, Perk Y, Ilter O, Aydinli K, et al. Transplacental passage of hepatitis B virus DNA from hepatitis B e antigen-negative mothers and delayed immune response in newborns. J Infect Dis. 1994;169(3):704-6. doi: 10.1093/infdis/169.3.704. [PubMed: 8158060].
  • 26. Abdelhamed AM, Kelley CM, Miller TG, Furman PA, Isom HC. Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. J Virol. 2002;76(16):8148-60. [PubMed: 12134020].
  • 27. Lin CL, Yang HC, Kao JH. Hepatitis B virus: new therapeutic perspectives. Liver Int. 2016;36 Suppl 1:85-92. doi: 10.1111/liv.13003. [PubMed: 26725903].
  • 28. Koniger C, Wingert I, Marsmann M, Rosler C, Beck J, Nassal M. Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses. Proc Natl Acad Sci U S A. 2014;111(40):E4244-53. doi: 10.1073/pnas.1409986111. [PubMed: 25201958].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments